Hasil Pencarian - Shilpak Chatterjee

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    CD38: T Cell Immuno-Metabolic Modulator

    CD38: T Cell Immuno-Metabolic Modulator oleh Anwesha Kar, Shikhar Mehrotra, Shilpak Chatterjee

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Editorial: Signaling pathways behind immune evasion and therapy resistance

    Editorial: Signaling pathways behind immune evasion and therapy resistance oleh Elena Martin-Orozco, Lisheng Wang, Shilpak Chatterjee, Brent A. Hanks

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse.

    Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse. oleh Shahid Husain, Yasir Abdul, Christine Webster, Shilpak Chatterjee, Pravin Kesarwani, Shikhar Mehrotra

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate.

    Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate. oleh Avishek Ganguly, Soumya Basu, Paramita Chakraborty, Shilpak Chatterjee, Avijit Sarkar, Mitali Chatterjee, Soumitra Kumar Choudhuri

    Diterbitkan 2010-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Intratumoral PD1<sup>+</sup>CD38<sup>+</sup>Tim3<sup>+</sup> CD8<sup>+</sup> T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer

    Intratumoral PD1<sup>+</sup>CD38<sup>+</sup>Tim3<sup>+</sup> CD8<sup>+</sup> T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patien... oleh Debashree Basak, Soumya Mondal, Swadeep Kumar Srivastava, Deborpita Sarkar, Ishita Sarkar, Sukanya Basu, Arpita Bhoumik, Snehanshu Chowdhury, Dilip Kumar Pal, Shilpak Chatterjee

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta

    Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta oleh In-Hong Kang, Uday K. Baliga, Shilpak Chatterjee, Paramita Chakraborty, Seungho Choi, Nathan Buchweitz, Hong Li, Yongren Wu, Hai Yao, Shikhar Mehrotra, Meenal Mehrotra

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19

    Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 oleh Daizee Talukdar, Purbita Bandopadhyay, Yogiraj Ray, Shekhar Ranjan Paul, Jafar Sarif, Ranit D’Rozario, Abhishake Lahiri, Santanu Das, Debaleena Bhowmick, Shilpak Chatterjee, Bhabatosh Das, Dipyaman Ganguly

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells.

    A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells. oleh Shilpak Chatterjee, Ananda Mookerjee, Jayati Mookerjee Basu, Paramita Chakraborty, Avishek Ganguly, Arghya Adhikary, Debanjan Mukhopadhyay, Sudipto Ganguly, Rajdeep Banerjee, Mohammad Ashraf, Jaydip Biswas, Pradeep K Das, Gourisankar Sa, Mitali Chatterjee, Tanya Das, Soumitra Kumar Choudhuri

    Diterbitkan 2009-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19

    Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19 oleh Ranit D’Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, Jafar Sarif, Priyanka Mehta, Chinky Shiu Chen Liu, Bishnu Prasad Sinha, Jayasree Roy, Ritwik Bhaduri, Monidipa Das, Sanghamitra Bandyopadhyay, Shekhar Ranjan Paul, Shilpak Chatterjee, Rajesh Pandey, Yogiraj Ray, Dipyaman Ganguly

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19

    Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19 oleh Deblina Raychaudhuri, PhD, Purbita Bandopadhyay, MS, Ranit D’Rozario, MS, Jafar Sarif, MS, Yogiraj Ray, MBBS, MD, DM, Shekhar Ranjan Paul, MBBS, DTCD, Praveen Singh, MS, Kausik Chaudhuri, MBBS, MD, Ritwik Bhaduri, MS, Rajesh Pandey, PhD, Prasun Bhattacharya, MBBS, MD, Shantanu Sengupta, PhD, Shilpak Chatterjee, PhD, Dipyaman Ganguly, MBBS, PhD

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity

    Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity oleh Paramita Chakraborty, Silvia G. Vaena, Krishnamurthy Thyagarajan, Shilpak Chatterjee, Amir Al-Khami, Shanmugam Panneer Selvam, Hung Nguyen, Inhong Kang, Megan W. Wyatt, Uday Baliga, Zachariah Hedley, Rose N. Ngang, Beichu Guo, Gyda C. Beeson, Shahid Husain, Chrystal M. Paulos, Craig C. Beeson, Michael J. Zilliox, Elizabeth G. Hill, Meenal Mehrotra, Xue-Zhong Yu, Besim Ogretmen, Shikhar Mehrotra

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

    A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 oleh Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Ritwik Bhaduri, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19

    Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19 oleh Jafar Sarif, Jafar Sarif, Deblina Raychaudhuri, Ranit D’Rozario, Ranit D’Rozario, Purbita Bandopadhyay, Purbita Bandopadhyay, Praveen Singh, Praveen Singh, Priyanka Mehta, Md. Asmaul Hoque, Md. Asmaul Hoque, Bishnu Prasad Sinha, Bishnu Prasad Sinha, Manoj Kushwaha, Shweta Sahni, Priti Devi, Priti Devi, Partha Chattopadhyay, Partha Chattopadhyay, Shekhar Ranjan Paul, Yogiraj Ray, Yogiraj Ray, Kausik Chaudhuri, Sayantan Banerjee, Debajyoti Majumdar, Debajyoti Majumdar, Bibhuti Saha, Biswanath Sharma Sarkar, Prasun Bhattacharya, Shilpak Chatterjee, Sandip Paul, Pramit Ghosh, Rajesh Pandey, Rajesh Pandey, Shantanu Sengupta, Shantanu Sengupta, Dipyaman Ganguly, Dipyaman Ganguly

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: